Effectiveness and safety of blonanserin for improving social and cognitive functions in patients with first-episode schizophrenia: a study protocol for a prospective, multicentre, single-arm clinical trial

INTRODUCTION: Both the pharmacological characteristics of blonanserin and its related small sample size studies suggest that blonanserin could alleviate social and cognitive dysfunctions in patients with schizophrenia. However, no large sample size studies have been performed so far. This study aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Chengcheng, Lei, Lei, Yang, Fude, Deng, Hong, Sheng, Jianhua, Liu, Zhening, Hu, Shaohua, Wang, Lina, Wu, Bin, Bo, Qijing, Inoue, Yoshifumi, Yu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021809/
https://www.ncbi.nlm.nih.gov/pubmed/35443947
http://dx.doi.org/10.1136/bmjopen-2021-054079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021809/
https://www.ncbi.nlm.nih.gov/pubmed/35443947
http://dx.doi.org/10.1136/bmjopen-2021-054079

Ejemplares similares